Found: 15
Select item for more details and to access through your institution.
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 1, p. 161, doi. 10.1111/bjh.13574
- By:
- Publication type:
- Article
machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq data.
- Published in:
- Bioinformatics, 2022, v. 38, n. 21, p. 4885, doi. 10.1093/bioinformatics/btac617
- By:
- Publication type:
- Article
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46424-3
- By:
- Publication type:
- Article
Telomere dysfunction induces metabolic and mitochondrial compromise.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Telomere dysfunction induces metabolic and mitochondrial compromise.
- Published in:
- Nature, 2011, v. 470, n. 7334, p. 359, doi. 10.1038/nature09787
- By:
- Publication type:
- Article
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells.
- Published in:
- Nature, 2010, v. 468, n. 7324, p. 701, doi. 10.1038/nature09595
- By:
- Publication type:
- Article
Case report Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
P-106: Targeting DNA2 overcomes myeloma cells' metabolic reprogramming in response to DNA damage.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S96, doi. 10.1016/S2152-2650(21)02240-0
- By:
- Publication type:
- Article
A Primer on the Biology of MDS.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S30, doi. 10.1016/S2152-2650(21)01198-8
- By:
- Publication type:
- Article
ILF2 antisense oligonucleotide therapy and CRISPR/Cas9-based screening for DNA repair effectors identify synthetic lethal approaches to enhancing myeloma cells' sensitivity to DNA damage.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e104, doi. 10.1016/j.clml.2019.09.171
- By:
- Publication type:
- Article
PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 351, doi. 10.1002/ajh.24650
- By:
- Publication type:
- Article
Corrigendum: Passenger deletions generate therapeutic vulnerabilities in cancer.
- Published in:
- 2015
- By:
- Publication type:
- Correction Notice
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
- Published in:
- Nature, 2014, v. 514, n. 7524, p. 628, doi. 10.1038/nature13611
- By:
- Publication type:
- Article
Passenger deletions generate therapeutic vulnerabilities in cancer.
- Published in:
- Nature, 2012, v. 488, n. 7411, p. 337, doi. 10.1038/nature11331
- By:
- Publication type:
- Article